DUBLIN--(BUSINESS WIRE)--The "Global Aesthetic Medicine Market (2022-2027) by Type, Gender, End-Users, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Aesthetic Medicine Market is estimated to be USD 98.7 Bn in 2022 and is expected to reach USD 157.52 Bn by 2027, growing at a CAGR of 9.80%
Market Dynamics
Drivers
- Rising Prevalence of Obesity Worldwide
- Increasing Awareness regarding Aesthetic Procedures and Adoption of Non-invasive Procedures
Restraints
- High Costs Associated with Aesthetic Procedures
Opportunities
- Technological Advancements Associated with Medical Aesthetic Devices
- Commercialization of Innovative Regenerative Medical Products
- Growing Medical Tourism
Challenges
- Limited Reimbursement Policies and Stringent Government Regulatory
Market Segmentations
The Global Aesthetic Medicine Market is segmented based on Type, Gender, End-Users, and Geography.
- By Type, the market is classified into Invasive Procedures, and Non-Invasive Procedures.
- By Gender, the market is classified into Female, and Male.
- By End-Users, the market is classified into Ambulatory Surgical Center, Beauty Center & Medical Spa, Dermatology Clinic, Home Setting, and Hospital.
- By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.
Countries Studied
- America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
- Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
- Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
- Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Aesthetic Medicine Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
The analyst analyses the Global Aesthetic Medicine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global Aesthetic Medicine Market, By Type
7 Global Aesthetic Medicine Market, By Gender
8 Global Aesthetic Medicine Market, By End-Users
9 Americas' Aesthetic Medicine Market
10 Europe's Aesthetic Medicine Market
11 Middle East and Africa's Aesthetic Medicine Market
12 APAC's Aesthetic Medicine Market
13 Competitive Landscape
14 Company Profiles
15 Appendix
Companies Mentioned
- Aesthetics Biomedical, Inc.
- Allergan, PLC
- Alma Medical, Pvt Ltd.
- Alumier Labs, Inc.
- Bioxis Pharmaceuticals SAS
- Cutera, Inc.
- Cynosure, Inc.
- Cytrellis Biosystems, Inc.
- El.En. S.p.A.
- Fotona d.o.o.
- Galderma Laboratories, L.P.
- Lumenis, Ltd.
- Medytox, Inc.
- Merz Aesthetics, Inc.
- Sientra, Inc.
- Sinclair Pharma, PLC
- Skin Tech Pharma Group
- Solta Medical International, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/fm4qdf
